NCT03733990 2025-04-02A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)Faron Pharmaceuticals LtdPhase 1/2 Completed216 enrolled 17 charts